Comparison of Radical Prostatectomy and Iodine 125 Interstitial Radiotherapy for the Treatment of Clinically Localized Prostate Cancer: A 7-Year Biochemical (PSA) Progression Analysis
Open Access
- 1 June 1998
- Vol. 51 (6) , 884-890
- https://doi.org/10.1016/s0090-4295(98)00153-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinomaCancer, 1997
- Long-Term Results of Retropubic Permanent 125 Iodine Implantation of the Prostate for Clinically Localized Prostatic CancerJournal of Urology, 1997
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- DOES BRACHYTHERAPY HAVE A ROLE IN THE TREATMENT OF PROSTATE CANCER?Hematology/Oncology Clinics of North America, 1996
- Prediction of Progression Following Radical ProstatectomyThe American Journal of Surgical Pathology, 1996
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- 5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate CancerJournal of Urology, 1994
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- Correlation of pathologic findings with progression after radical retropubic prostatectomyCancer, 1993